Model DetailsLeukocyte lymphoma
Model Name |
Leukocyte lymphoma | Strain |
CD-1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
hematopoietic neoplasm • L, lymphoma, subtype uncertain • hematopoietic tumor • systemic lymphoma • lymphoma • hemato neoplasia, lymphoma • malignant lymphoma |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Leukocyte | Unspecified |
1.5% |
up to 20 months |
|
Lavigueur A, Mol Cell Biol 1989 Sep;9(9):3982-91 |
| Leukocyte | Male |
low |
|
Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 | |
| Leukocyte | Female |
low |
|
Takahashi O, Toxicology 1997 Dec 26;124(2):95-103 | |
| Leukocyte | Female |
30% (10 of 33 mice) |
90 weeks |
|
Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |
| Leukocyte | Male |
11.4% (8 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
4.3% (3 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
18.75% (12 of 64 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
5.7% (4 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
4.3% (3 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
7.1% (5 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
5.7% (4 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
7.1% (5 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
5.7% (4 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
7.1% (5 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
11.1% (8 of 72 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
8.0% (61 of 766 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
20% (14 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
25.7% (18 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
29.7% (19 of 64 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
28.6% (20 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
12.9% (9 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
22.9% (16 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
21.4% (15 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
20% (14 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
8.6% (6 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
14.3% (10 of 70 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
20.8% (15 of 72 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
20.4% (156 of 766 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
8.1% (72 of 891 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Female |
22.0% (196 of 890 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Leukocyte | Male |
6.7% (4 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Leukocyte | Male |
13% (8 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Leukocyte | Female |
18% (11 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Leukocyte | Female |
17% (10 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Leukocyte | Male |
1.7% (1 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Leukocyte | Female |
12% (7 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Leukocyte | Female |
0% (0 of 31 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte | Female |
0% (0 of 23 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte | Female |
0% (0 of 54 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte | Male |
0% (0 of 31 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte | Male |
9.5% (2 of 21 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte | Male |
3.8% (2 of 52 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Leukocyte | Mixed Population |
observed |
≥1 year |
|
Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 |
| Leukocyte | Male |
0.07% (1 of 1453 mice) |
up to 10 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte | Male |
0.21% (3 of 1453 mice) |
up to 20 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte | Male |
0.34% (5 of 1453 mice) |
up to 30 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte | Male |
0.76% (11 of 1453 mice) |
up to 40 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte | Male |
1.58% (23 of 1453 mice) |
up to 50 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte | Female |
0% (0 of 1453 mice) |
up to 20 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte | Female |
0.34% (5 of 1453 mice) |
up to 30 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte | Female |
0.96% (14 of 1453 mice) |
up to 40 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Leukocyte | Female |
1.31% (19 of 1453 mice) |
up to 50 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |